Background: BK channels regulate smooth muscle contractility and provide docking site for steroids, such as bile acids. Results: Non-steroid leukotriene B4 activates the BK channel via a steroid-sensing site. Conclusion: Physiological lipids from different chemical families share their recognition site in BK proteins. Significance: Our data underscore a likely cross-talk between different physiological lipids in BK channel-driven pathophysiology.
Calcium/voltage-gated, large conductance potassium (BK) channels control numerous physiological processes, including myogenic tone. BK channel regulation by direct interaction between lipid and channel protein sites has received increasing attention. Leukotrienes (LTA4, LTB4, LTC4, LTD4, and LTE4) are inflammatory lipid mediators. We performed patch clamp studies in Xenopus oocytes that co-expressed BK channel-forming (cbv1) and accessory ␤1 subunits cloned from rat cerebral artery myocytes. Leukotrienes were applied at 0.1 nM-10 M to either leaflet of cell-free membranes at a wide range of [Ca 2؉ ] i and voltages. Only LTB4 reversibly increased BK steady-state activity (EC 50 ‫؍‬ 1 nM; E max reached at 10 nM), with physiological [Ca 2؉ ] i and voltages favoring this activation. Homomeric cbv1 or cbv1-␤2 channels were LTB4-resistant. Computational modeling predicted that LTB4 docked onto the cholane steroidsensing site in the BK ␤1 transmembrane domain 2 (TM2). Co-application of LTB4 and cholane steroid did not further increase LTB4-induced activation. LTB4 failed to activate ␤1 subunit-containing channels when ␤1 carried T169A, A176S, or K179I within the docking site. Co-application of LTB4 with LTA4, LTC4, LTD4, or LTE4 suppressed LTB4-induced activation. Inactive leukotrienes docked onto a portion of the site, probably preventing tight docking of LTB4. In summary, we document the ability of two endogenous lipids from different chemical families to share their site of action on a channel accessory subunit. Thus, cross-talk between leukotrienes and cholane steroids might converge on regulation of smooth muscle contractility via BK ␤1. Moreover, the identification of LTB4 as a highly potent ligand for BK channels is critical for the future development of ␤1-specific BK channel activators.
Regulation of cell physiology by direct targeting of cell membrane ion channel proteins by lipid signaling molecules represents an area of expanding investigation (1) . In particular, lipid regulation of Ca 2ϩ -and voltage-gated potassium channels of large conductance (BK) 3 has received increasing attention because these channels control numerous physiological processes, such as smooth muscle tone, neuronal firing, hormonal release, immune responses, and cancer cell growth (2) (3) (4) . Functional BK channels result from tetrameric association of the ubiquitously expressed ␣ (slo1) subunit, which contains an S1-S6 transmembrane (TM) core common to other voltagegated ion channels of the TM6 superfamily (2) . In most tissues, however, BK complexes include small accessory proteins (two TM helices) termed ␤ subunits (2) . Four types of ␤ subunits (␤1-4) have been identified, with highly distinct and tissuespecific expression profiles (5, 6) . Each ␤-subunit type empowers the BK channel complex with a distinct phenotype, which allows this family of channels to contribute to cell physiology in a tissue-specific manner and opens the possibility to selectively modify tissue function by targeting specific BK ␤ type(s). For example, BK ␤1 allows the BK channel to activate in response to physiological voltage and [Ca 2ϩ ] i found in contracting smooth muscle cells. Upon activation, BK channels generate outward potassium currents that oppose membrane depolarization (2) . Thus, activation of ␤1-containing BK channels is a powerful mechanism to evoke smooth muscle relaxation, a desirable end point to treat prevalent human conditions, including bronchial asthma, pulmonary hypertension, overactive bladder, vascular spasm, and arterial hypertension.
Specific sites for lipid modulation have been identified in both slo1 and BK ␤ subunits. For instance, cholesterol regulates BK channel activity by interacting with several cholesterol recognition amino acid consensus motifs located along the slo1 cytosolic tail domain (7) . Phosphatidylinositol 4,5-bisphosphate and related phosphoinositides also interact with slo1, yet their recognition site involves an RKK triplet located immediately after S6 (8) . In contrast, a diverse group of lipids requires the presence of accessory ␤ subunits within the BK complex for BK current modulation. 17␤-Estradiol activates BK channels in the presence of the ␤1 subunit (9) . On the other hand, fatty acid-induced BK channel activation is best observed in the presence of ␤1 or ␤4 subunits (10) . Finally, cholane steroids increase BK channel activity by specific interaction with a discrete site located in the BK ␤1 TM2 (11) (12) . This site is unique to ␤1 and is not present in other ␤ subunits. In all cases, the lipid effect on BK channel function was observed in cell-free membrane patches. Therefore, a wide variety of physiologically important lipids is likely to alter BK channel activity and, thus, tissue function by selective interaction with distinct sites located in the BK slo1 or ␤ subunits.
Leukotrienes (LTA4, LTB4, LTC4, LTD4, and LTE4) are important inflammatory mediators (derived from arachidonic acid via the 5-lipoxygenase pathway) that exert their physiological effects by activating G protein-coupled receptors (13) . Circulating levels of leukotrienes in health and disease do not reach micromolar levels (14 -16) . The chemical structure of these endogenous lipids includes a long hydrophobic backbone and at least one carboxylic acid end group (Fig. 1) . Here we demonstrate that LTB4 activates BK channels by direct interaction with the cholane steroid-sensing site located in the BK ␤1 TM2. This finding is critical for the future development of ␤1-specific BK channel activators. Moreover, we demonstrate that LTB4 activates BK channels with an unusually high potency (EC 50 ϭ 1 nM). The fact that the EC 50 value matches physiologically relevant levels of LTB4 in the vascular system raises speculation that cross-talk between endogenous leukotrienes and cholane steroids may converge to regulate smooth muscle contractility via BK ␤1 targeting. care of animals and experimental protocols were reviewed and approved by the Animal  Care and Use Committee of the University of Tennessee Health  Science Center, an institution accredited by the Association for  Assessment and Accreditation of Laboratory Animal Care. cRNA Preparation-Cloning, expression, and functional characterization of cbv1 (AY330293) are described elsewhere (17, 18) . ␤1 cDNA from rat cerebral artery smooth muscle cells (FJ154955) was subcloned into pOX vector and expressed as described (18) . Targeted mutations were introduced into r␤1 cDNA by using overlap-extension polymerase chain reaction (PCR) and QuikChange (Stratagene) with Pfu polymerase following the manufacturer's instructions. In the PCR-amplified regions of all constructs, the presence of targeted mutations and the absence of unintended mutations were verified by automated sequencing at the Molecular Resource Center (University of Tennessee Health Science Center). The cDNA coding for the ␤2 subunit without its N-type inactivation domain (␤2IR) (a generous gift from Dr. Ligia Toro; UCLA) was subcloned into pOX vector for expression in oocytes. ␤1 and ␤2IR cDNAs inserted into pOX vectors were linearized and then transcribed in vitro by using the mMessage mMachine transcription kit with T3 and T7 polymerase, respectively (Ambion). cRNA was dissolved in diethyl polycarbonate-treated water at 10 (cbv1) and 30 (␤1 or ␤2IR) ng/l; 1-l aliquots were stored at Ϫ70°C.
MATERIALS AND METHODS

Ethical Aspects of Research-The
Oocyte Extraction and cRNA Injection-Xenopus laevis females were purchased from Xenopus Express and maintained in artificial pond water on a 12-h light/dark cycle. In this habitat, the females do not show seasonal breeding behavior, so oocytes are available throughout the year. Stage V and VI oocytes were predominantly used because they transcribe mRNA into channels efficiently. Six frogs were used as oocyte donors. Before surgery, the frogs were anesthetized by placement on ice after exposure to ethyl 3-aminobenzoate methanesulfonate salt (250 mg/liter, pH 7.4). Oocytes were removed and kept in Ca 2ϩ -free ND-96 solution (82.5 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, pH 7.5) containing 2 mg/ml type IV collagenase (Sigma-Aldrich) in a shaker (60 oscillations/min) at room temperature for 15 min to remove the follicular layer. After defolliculation, oocytes were transferred to Ca 2ϩ -containing ND-96 saline (82.5 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 5 mM HEPES, pH 7.4), supplemented with 2.5 mM sodium pyruvate and 2 mg/ml gentamicin. Injection of mRNA into the oocyte cytoplasm was conducted using a Drummond micropipette modified for microinjection (Drummond Scientific Co.). The interval between cRNA injection and patch clamping was 36 -48 h, during which time oocytes were kept at 15°C.
Electrophysiology Data Acquisition and Analysis-Before electrophysiological recording, oocytes were placed into a dish containing a hypertonic solution (200 mM K ϩ aspartate, 20 mM KCl, 1 mM MgCl 2 , 10 mM EGTA, 10 mM HEPES, pH 7.4) for 10 min. With this treatment, the oocytes shrank, allowing the removal of the vitelline layer with forceps and exposing the oocyte membrane for subsequent patch clamp recording. Then oocytes were placed back into ND-96 saline (in this case without gentamicin; for the composition, see above) for 10 -15 min Patch clamp electrodes were pulled from glass capillaries (Drummond Scientific Co.). Immediately before recording, the tip of the electrode was fire-polished on a microforge (World Precision Instruments) to give resistances of 8 -10 megaohms when filled with extracellular solution (for composition, see above). An agar bridge with gluconate as main anion was used as the ground electrode. After excision from the cell, the membrane patch was exposed to a stream of bath solution containing each agent at final concentration. Solutions were applied onto the patch cytosolic side by using a pressurized, automated OctaFlow perfusion system (ALA Scientific Instruments) via a micropipette tip with an internal diameter of 100 m. Experiments were performed at room temperature (20 -22°C).
Ionic current was recorded using an EPC8 amplifier (HEKA, Lambrecht, Germany) at 1 kHz. Data were digitized at 5 kHz by using a Digidata 1320A A/D converter and pCLAMP version 8.0 (Molecular Devices).
Computational Modeling-The leukotriene molecular structures were built using the Molecular Operating Environment 2013.08 software package (Chemical Computing Group) with the carboxylic acid in the negatively charged form expected at physiological pH. The structures were minimized using the MMFF94x force field. A flexible superposition was performed with lithocholic acid (LCA) and leukotriene B4 using default settings in Molecular Operating Environment. The previously described model of the ␤1 TM2 (15) was used to dock all leukotrienes on the steroid-sensing site. The Induced Fit docking protocol in Molecular Operating Environment was used, and residues Thr-169 and Lys-179 were selected as the receptor site for the simulation. All other options were left at default settings.
Chemicals-LTA4 methyl ester, LTB4, LTC4, LTD4, and LTE4 were purchased from Cayman Chemical Co. All other chemicals were purchased from Sigma-Aldrich. Immediately before experiments, leukotriene A4 methyl ester was hydrolyzed to render LTA4 following the manufacturer's instructions. Because LTB4, LTC4, LTD4, and LTE4 were supplied in ethanol solution, on the day of experiments, an LT-containing aliquot was dried under an N 2 atmosphere to evaporate ethanol. The remaining leukotriene was resuspended in patch clamp recording solution to final concentration.
Data Analysis-For patch clamp recording at single-channel resolution, we used NP o as the index of channel steady-state activity, with NP o being the product of the number of channels in the patch (N) and the individual channel open probability (P o ). NP o was obtained using a built-in function in Clampfit version 9.2 software (Molecular Devices) (19, 20) . NP o was obtained from 1 min of gap-free recording under each condition.
Final plotting, fitting, and statistical analysis of data were conducted using Origin version 8.5.1 (OriginLab) and InStat version 3.0 (GraphPad). Statistical analysis was conducted using either one-way analysis of variance and Bonferroni's multiple comparison test or paired Student's t test, according to the experimental design. Statistical significance was set at p Ͻ 0.05. Data are expressed as mean Ϯ S.E., and n ϭ number of patches. Each patch was obtained from a different oocyte.
RESULTS
LTB4, but Not Other Leukotrienes of the LT4
Family, Activated ␤1 Subunit-containing BK Channels-To determine the leukotriene ability to modulate BK channel function, we tested leukotriene action on recombinant channels heterologously expressed in Xenopus oocytes. This expression system has been extensively validated by us and by others to study basic function and lipid modulation of recombinant channels with a subunit composition that matches that of the native smooth muscle BK protein complex (8, 11, 21, 22) : BK channel-forming ␣ ("cbv1"; AY330293) and accessory ␤1 (FJ154955) subunits from freshly isolated rat cerebral artery myocytes. The resulting recombinant BK complex represents an ideal model of the native ␤1 subunit-containing BK channel (18) . We used I/O patches with the membrane potential and free [Ca 2ϩ ] i set at values that were close to those reported in the rat cerebrovascular myocyte during contraction (Ϫ40 to Ϫ25 mV and 10 M). Under these physiological conditions, BK channel activity plays a critical role in limiting depolarization-induced Ca 2ϩ entry and thus opposes smooth muscle contraction (23) (24) (25) . After excision, each patch was exposed to control solution, and BK activity was continuously recorded for 1 min. The presence of functional ␤1 subunits within the cbv1-␤1 complex was confirmed by the characteristic decrease in voltage that was needed to reach halfmaximal current (V half ): 20 Ϯ 2.7 and Ϫ20 Ϯ 1.7 mV for cbv1 and cbv1-␤1, respectively. This macroscopic current phenotype matched what was previously described by us and others (5, 18, 26) .
Application of the LTB4-containing (0.1 nM to 10 M) solution reversibly increased cbv1-␤1 NP o up to 2-fold in a concentration-dependent manner: EC 50 ϳ1 nM, with E max being reached at ϳ10 nM (Fig. 2, A and B) . However, other members of the LT4 family (LTA4, LTC4, LTD4, and LTE4) were ineffective in changing cbv1-␤1 NP o even when tested at 1 M, which is 10-fold more than needed to invoke E max by LTB4 (Fig.  2, C and D) . This lack of efficacy of LTA4, LTC4, LTD4, and LTE4 could potentially arise from the difficulty that polar/ charged lipids could have in reaching a site located inside the bilayer or in the vicinity of the extracellular side of the membrane patch when the polar lipid accesses the membrane from its cytosolic side. Thus, we tested leukotriene's effect on cbv1-␤1 complexes in outside-out (O/O) patches, where agents of interest were perfused onto the extracellular side of the membrane. In O/O patches, the LTB4-induced cbv1-␤1 channel activation was similar to that observed in I/O patches (Fig.  2E ). Also consistent with data from I/O patches, LTA4, LTC4, LTD4, and LTE4 (1 M) all failed to increase cbv1-␤1 NP o when applied to the extracellular side of O/O patches (Fig. 2E) . Therefore, among the LT4 lipids tested, LTB4 was the only one that effectively activated cbv1-␤1 channels, this action being independent of the membrane leaflet from which the leukotriene accesses the channel complex.
To gain additional insight into the LTB4-induced BK channel activation, we addressed how lipid action related to basal channel activity and its voltage and Ca 2ϩ dependence. The LTB4-induced increase in BK channel activity inversely correlated with basal channel activity (i.e. the channel's P o before LTB4 application) (Fig. 3A) . This is somewhat expected for most ion channel activators, because channels with a basal (i.e. pre-agonist) open probability that gets closer to 1 cannot be opened much more (ceiling effect). Next, we explored a possible relationship between the LTB4-induced increase in BK channel activity and the voltage and Ca 2ϩ dependence of BK NP o . The LTB4-induced increase in BK NP o correlated poorly with transmembrane voltage (Fig. 3B) . On the other hand, a plot of LTB4-induced BK channel activation versus [Ca 2ϩ ] i exhibited a complex shape (Fig. 3C) LTB4 Activation of BK Channel Required the Presence of BK ␤1 Subunit within the Channel Complex-LTB4-induced activation of cbv1-␤1 channels in excised patches indicated that this LTB4 action did not require the continuous presence of cytosolic factors or intracellular organelles. Therefore, it is conceivable that LTB4-induced activation of BK channels results from a direct recognition of LTB4 by the BK protein complex and/or its surrounding lipids. To determine the role of individual BK channel subunit types in LTB4 sensitivity, we tested LTB4 action on homomeric cbv1 channels heterologously expressed in Xenopus oocytes. Under experimental conditions identical to those used to study leukotriene action on cbv1-␤1 complexes (see above), LTB4 caused a negligible increase in cbv1 NP o even when applied at 10 M (Fig. 4, A and B) . A lack of LTB4-induced activation of homomeric cbv1 channels was observed across a wide range of [Ca 2ϩ ] i levels (Fig. 4C) . Thus, our results point at the BK ␤1 subunit as the molecular sensor of LTB4.
To begin to determine the specificity of LTB4 recognition by BK ␤1, we next tested whether ␤ subunits other than ␤1 could confer LTB4 sensitivity to BK channels. Thus, we tested LTB4 on cbv1-␤2IR complexes. At micromolar [Ca 2ϩ ] i , ␤2IR-containing BK channels possess Ca 2ϩ sensitivity similar to that of ␤1-containing channels (22) . Remarkably, LTB4 repeatedly failed to increase cbv1-␤2IR NP o to the levels obtained when the lipid was applied to cbv1-␤1 (Fig. 4, D and E) . Considering that 1) among ␤2-4 proteins, ␤2 has the highest identity/similarity of amino acid sequence with ␤1 (5), and 2) unlike ␤1, ␤2 does not confer LTB4 sensitivity to BK channel (current data), it is likely that ␤3 or ␤4 would not confer such sensitivity. Conceivably, ␤1 versus other ␤ subunits may have the unique ability to enable LTB4-induced BK channel activation.
LTB4 Activates BK Channels via the Steroid-sensing Site on the BK ␤1 Subunit TM2-In previous work, we demonstrated that ␤1 subunits contain a recognition site for negatively charged cholane steroids that is not shared by ␤2-4 subunits. This site is located within the ␤1 TM2 region and requires the presence of a polar hydroxyl group within the steroid nucleus and a negatively charged carboxyl at the lateral chain of the cholane steroid molecule for ligand recognition to evoke channel activation (11, 28 -29) . To be an effective BK channel activator, the steroid molecule should be able to adopt a bean-like shape, which is characteristic of bile acids (11, 28) . Therefore, we first compared a three-dimensional structure of LTB4 with LCA, the most effective cholane steroid activator of BK channels. Flexible superposition of these two molecules results in spatial overlap of critically important features: hydroxyl and carboxyl groups (Fig. 5A) . Also, the linear but flexible LTB4 molecule is able to align along the bean-shaped LCA molecule (Fig. 5A) . Therefore, from a ligand topology point of view, the cholane steroid-sensing site on the BK ␤1 TM2 domain represents an attractive candidate for LTB4 recognition, which results in BK channel activation.
Docking of LCA onto the BK ␤1 steroid-sensing site involves hydrogen bonding of the LCA hydroxyl group with Thr-169 and hydrophobic interactions of the LCA steroid nucleus with Leu-172 and Leu-173 (Fig. 5B) (12) . Although Ala-176 and Lys-179 are located in the vicinity of the LCA lateral chain, amino acid substitutions at these positions failed to affect LCA-induced BK channel activation (12, 28) . Thus, Ala-176 and Lys-179 were ruled out as steroid-sensing amino acids.
Like LCA, docking of LTB4 onto the BK ␤1 TM2 domain's steroid-sensing site resulted in hydrogen bonding of one of the LTB4 hydroxyl groups with Thr-169 and placement of the LTB4 hydrocarbon chain on the hydrophobic surface formed by Leu-172 and Leu-173 (Fig. 5C, left) . Unlike LCA, docking of Leukotriene B4 and BK Channels DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51
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LTB4 yielded a very tight association of the LTB4 hydrocarbon chain with the receptor surface formed by Ala-176 (Fig. 5C,  right) . LTB4 was also expected to form a hydrogen bond with Lys-179 (Fig. 5C, left) . Therefore, in addition to previously validated steroid-sensing residues Thr-169, Leu-172, and Leu-173, the additional residues Ala-176 and Lys-179 may participate in LTB4 recognition and retention by the BK ␤1 TM2.
To validate our computational results, we 1) applied a mixture of LTB4 and LCA onto the cbv1-␤1 channels and 2) tested LTB4 on cbv1-␤1 complexes that contained substitutions of amino acids that conform the docking site. Co-application of LTB4 with LCA at concentrations that resulted in maximal BK channel activation (1 and 150 M, respectively) failed to show additivity in increasing NP o (Fig. 5, D and E) . The 1.5-fold increase in the presence of both agonists is similar to that observed in the presence of either (Fig. 5E ).
Next, we tested LTB4 on cbv1-␤1 complexes with substitutions of amino acids that are predicted to form the LCA/LTB4 docking site. T169A has been proven to serve as a screening tool to identify possible ligands for the BK ␤1 TM2 domain steroidsensing site (12, 30) . Successful expression of ␤1T169A and its presence within the channel complexes were validated by detecting the ␤1 subunit-characteristic phenotype of cbv1-␤1T169A macroscopic current (12) . As expected from computational data, LTB4 repeatedly failed to increase cbv1-␤1T169A NP o when tested under experimental conditions identical to those used to study leukotriene action on cbv1-␤1 complexes (see above) (Fig. 6, A and C) . However, LTB4-induced BK chan- Leukotriene B4 and BK Channels DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51 nel activation was still evident when we probed LTB4 on cbv1-␤1T165A complexes, the T165A substitution targeting a threonine residue located upstream and outside the steroid-sensing area (Fig. 6, B and C) . Collectively, our data underscore a distinct role for Thr-169 in LTB4 sensing by ␤1 subunit-containing BK channels. We also tested the role of Ala-176 and Lys-179 in LTB4-sensing by testing LTB4 on cbv1-␤1A176S and cbv1-␤1K179I channels. The functional presence of ␤1A176S and ␤1K179I within the channel complexes was validated by the observation of the characteristic macroscopic current phenotype of ␤1 subunit-containing BK channels, as was done for other channel constructs (see above). LTB4 repeatedly failed to increase NP o of cbv1-␤1A176S and cbv1-␤1K179I complexes when tested under experimental conditions identical to those used to study leukotriene action on cbv1-␤1 channels (Fig. 6, C-E) . These electrophysiological data are in agreement with our computational prediction regarding a critical role of Ala-176 and Lys-179 in LTB4 sensing (Fig. 5C ).
To determine whether leukotrienes that were unable to activate BK channels could also dock on the LTB4-sensing site, we tested BK channel activity in the presence of 1 M LTB4 mixed with a 1 M concentration of each of the non-activating leukotrienes: LTA4, LTC4, LTD4, and LTE4. In all cases, LTB4 failed to increase BK NP o in the presence of non-activating leukotrienes (Fig. 7A) . One possible explanation for the loss of LTB4 activity is that the non-activating leukotrienes still dock onto the LTB4-sensing site, but this docking does not transform into modifying channel activity but rather prevents LTB4 from docking. Alternatively, non-activating leukotrienes might dock elsewhere and either prevent LTB4 docking via allosteric mechanisms or decrease channel activity, thus counterbalancing LTB4-induced BK channel activation. Our computational docking data strongly favor the first possibility; all non-activating leukotrienes were able to dock onto the LTB4-sensing site ( Fig. 7B and Table 1 ). They form a hydrogen bond with Lys-179 and probably interact with hydrophobic amino acids within the site. In some cases, non-activating leukotrienes (LTA4 and LTC4) were unable to form a hydrogen bond with Thr-169, a key residue that is required for the LTB4-sensing site. In other cases (LTD4 and LTE4), hydrogen bond formation was quite possible, yet it would require an energetically unfavorable conformation of the LT4 molecule. In all cases, however, docking of non-activating leukotrienes on the LTB4-sensing site was expected to hinder LTB4 docking.
DISCUSSION
Regulation of ion channel function, of BK in particular, due to direct interaction between ion channel protein and physiologically relevant endogenous lipids represents a growing area of research (1, 31) . Indeed, several recent studies have shown direct modulation of BK channel function by fatty acids (10, 32) , phosphatidylinositol 4,5-bisphosphate and other phosphoinositides (8) , membrane phosphoglycerides (33) , and physiologically relevant steroids, including cholesterol (7, 34) , stress (35) and sex hormones (9), and bile acids and related cholane steroids (12, 28) . Here, we have demonstrated for the first time that LTB4, a member of the leukotriene family of lipids, is one of the most potent endogenous lipid activators of BK channels.
Previous studies have documented a modulatory action of leukotrienes on ion channels other than BK. LTC4 produces a concentration-dependent increase in steady-state, GTP␥S-mediated IK Ach current of bullfrog atrial myocytes (36) . LTD4, in turn, activates a chloride conductance in hepatocytes of lipopolysaccharide-treated rats (37) and both charybdotoxin-sensitive and -insensitive potassium channels in Ehrlich ascites tumor cells (38) . LTB4, in particular, mediates inflammation via TRPV1 in duct obstruction-induced pancreatitis in rats (39). This leukotriene also increases RyR-mediated currents in microsomes prepared from canine cerebellum (40) . In all of these studies of leukotriene-ion channel interactions, however, the mechanisms and site of leukotriene action remain undetermined. In the present work, we clearly demonstrate that BK channel modification of steady-state activity occurs at voltage and [Ca 2ϩ ] i levels that are not only physiological but also optimal for BK ␤1 subunit control of channel function (41) . Moreover, we identify for the first time this subunit as the LTB4 molecular sensor.
Remarkably, the BK ␤1 subunit represents a common target for several negatively charged lipids that increase BK channel activity. Indeed, the BK ␤1 subunit confers BK channel sensitivity to bile acids (12) and arachidonic acid (42) and significantly enhances phosphatidylinositol 4,5-bisphosphate-induced BK channel activation (8) . The second transmembrane domain of the BK ␤1 subunit contains the cholane steroidsensing site, which includes Thr-169, Leu-172, and Leu-173 (12) . In this work, we demonstrated that this site can also accommodate LTB4. Therefore, two endogenous lipids from different chemical groups (heterocyclic cholane steroids and linear leukotrienes) can share their site of action on an ion channel protein, an unusual phenomenon because lipid-sensing sites on ion channels, BK in particular, do not share ligands from different lipid species (1, 43) . The physiological implications of such overlap remain to be explored. However, our findings do not necessarily mean that the cholane steroid-sensing site could be targeted by any negatively charged lipid of physiological relevance known to regulate BK channel activity. For instance, docosahexaenoic acid activates BK currents via two amino acids located in the N terminus and first transmembrane region of the BK ␤1 protein (10) . Although these residues may play a regulatory role rather than provide the actual docking area for docosahexaenoic acid, docosahexaenoic acid lacks a hydroxyl group that could potentially interact with Thr-169 of the cholane-sensing site. Our studies clearly indicate that this interaction is critical for lipid-induced channel activation via the steroid-sensing site on the BK ␤1 TM2 domain, whether involving cholane steroids (11, 12, 29) , heterocyclic synthetic analogs (30), or LTB4 itself (Fig. 6) . Moreover, the presence of a hydroxyl group within the hydrocarbon core of LTB4 explains the unique ability of LTB4 to activate the BK channel when compared with other members of the LT4 family. Indeed, although LTA4, LTC4, LTD4, and LTE4 are able to dock onto the LTB4-sensing site and probably prevent LTB4 from effective docking, these non-activating leukotrienes do not possess a hydroxyl or any other polar group at a position in the molecule that would favor hydrogen bonding with Thr-169 (Fig. 7) .
A unique feature of LTB4-induced BK channel activation is the high potency of LTB4. Compared with other known BK channel activators (and lipid activators in particular), LTB4-induced BK channel activation could be observed at low nanomolar concentrations (EC 50 ϳ1 nM). Indeed, other known lipid activators of BK channel require tens of micromolar in concentration to increase channel activity (8, 28, 32, 44, 45) . Our data indicate that LTB4 is one of the most potent BK channel activators ever found (Fig. 2B) ; its potency is matched only by that of the synthetic agent bis(1,3-dibutylbarbituric acid)trimethine oxonol and the herb-derived dehydrosoyasaponin I, with these two agents being effective at 10 nM (46, 47) . The high potency of LTB4 when compared with other known BK channel activators can be explained by several factors, including unrestricted access to the transmembrane sensing site and an ability to occupy the site with high affinity. Bile acids, however, are known to cross biological membranes with ease (48), yet these cholane steroids require micromolar concentrations to evoke detectable increases in BK channel activity (11, 28) .
Our present results show significant hydrophobic contacts between the LTB4 molecule and the Leu-172, Leu-173, Ala-176 hydrophobic triplet. In contrast, this type of interaction is either minimal (for Leu-172 and Leu-173) or not present (for Ala-176) when LCA docks onto the site (12) . Moreover, a lack of hydrophobic interactions between LCA molecule and Leu-172, Leu-173, and Ala-176 may result in reduced binding affinity because it is generally accepted that adding a hydrophobic surface(s) to a series of analogs leads to an increase in ligandreceptor binding energy (49) . Therefore, a tight fit into the cholane-sensing site may explain or at least contribute to the exceptionally high potency of LTB4 (Figs. 5 and 7) when compared with the cholane steroids.
The high potency of LTB4 is attractive for a drug development effort to design a new class of potent BK channel activators. Another advantage of using LTB4 as a template for drug design stems from the ability of LTB4 to activate BK channels when applied to the extracellular side of the membrane (Fig.  2E) . In contrast, the highly potent dehydrosoyasaponin I is effective only when applied to the intracellular side of the membrane (46) . This fact limits the pharmaceutical potential of dehydrosoyasaponin I because dehydrosoyasaponin I-derived drugs would be ineffective when administered via conventional routes (e.g. intravenous delivery or oral administration). Finally, LTB-induced BK channel activation is favored by physiologically relevant levels of [Ca 2ϩ ] i (Fig. 3, B  and C) . This characteristic is also important for developing new therapeutic compounds.
In conclusion, we identified for the first time LTB4 as a novel activator of BK channels, such interaction requiring direct recognition by the channel regulatory ␤1 subunit, and documented the ability of endogenously produced lipids from dif- Leukotriene B4 and BK Channels DECEMBER 19, 2014 • VOLUME 289 • NUMBER 51
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ferent chemical groups to share a common sensing site on the ion channel accessory subunit.
